Michael Brooks
Net worth: 2 M $ as of 30/05/2026
Net worth: 2 M $ as of 30/05/2026
Michael Brooks is currently President at Edesa Biotech, Inc. since 2019, with employment at the company starting in 2015.
Former positions include Director-Business Development at Cipher Pharmaceuticals, Inc. from 2010 to 2015, President at Edesa Biotech, Inc. (Old), and Vice President-Corporate Development & Strategy at Edesa Biotech Research, Inc. Education includes an MBA from Rotman School of Management and undergraduate and doctorate degrees from the University of Toronto.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EDESA BIOTECH, INC. 3.28% | 26/05/2026 | 291,479 ( 3.28% ) | 2 M $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| EDESA BIOTECH, INC. | President | 06/06/2019 |
| Companies | Position | End |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Corporate Officer/Principal | 31/12/2014 |
Edesa Biotech Research, Inc. | Corporate Officer/Principal | - |
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Develops novel non-steroidal molecules for the treatment of allergic contact dermatitis | President | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Cipher Pharmaceuticals, Inc.
Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
Rotman School of Management
Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Develops novel non-steroidal molecules for the treatment of allergic contact dermatitis | Health Technology |
Edesa Biotech, Inc.
Edesa Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of chronic allergic contact dermatitis | Health Technology |
Edesa Biotech Research, Inc. |
Select your edition
All financial news and data tailored to specific country editions